Page Menu

Immunopathogenesis of Hidradenitis Suppurativa

Now enrolling: A $100 stipend is offered for full participation

Study PI: Sarah Whitley, MD, PhD
Sponsors: NIAMS/NIH, Hidradenitis Suppurativa Foundation.

The goal of this project is to identify novel therapeutic targets for HS by characterizing pathogenic immune cell types and delineating molecular signals that recruit and maintain these cells within skin. 


Participants will undergo skin biopsy and/or blood draw, skin swab, physical examination including vital signs, plus complete questionnaires

Time commitment

A single office visit lasting approximately 1 hour


Age 6 or older with or without hidradenitis suppurativa.